IP Library › Granted Patent US 12,349,914
Granted Patent B2
US 12,349,914 · App. 18/151,961 · Granted Jul 8, 2025

Anastomosis formation with magnetic devices having temporary retention member

Inventors: Michel Gagner (Montréal, CA); Todd A. Krinke (Buffalo, MN); Thierry Thaure (San Jose, CA)
Assignee: GT METABOLIC SOLUTIONS, INC.
A61B17/1114A61B2017/00004A61B2017/00876A61B2017/1135
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,349,914
App. No.
18/151,961
Granted
Jul 8, 2025
Kind
B2
Abstract

Systems and methods for forming an anastomosis between two adjacent walls of a digestive tract are provided. The system can include a first and second magnetic implants that are configured to magnetically couple to each other through the two adjacent walls of the digestive tract to compress a portion of the two adjacent walls therebetween and form a necrotic area that becomes surrounded by a scarred edge following a healing time period. The system can also include a retention member that can extend outwardly from a corresponding one of the first and second magnetic implants, the retention member being configured to retain the first and second magnetic implants in position and prevent passage thereof through the necrotic area during the healing time period.

Claims (38)

1. A system for forming an anastomosis between two adjacent walls of a digestive tract, the system comprising:

first and second elongated magnetic implants each comprising an outer side wall and a compression surface extending inwardly from a compression perimeter defined by the outer side wall, the first and second elongated magnetic implants being configured for placement within a corresponding hollow organ of the digestive tract and to magnetically couple to each other through the two adjacent walls of the digestive tract to compress a portion of the two adjacent walls therebetween and form a necrotic area via that becomes surrounded by a scarred edge following a healing time period; and

a retention member extending outwardly from the outer side wall of at least one of the first and second elongated magnetic implants to define a retention member perimeter that is larger than the compression perimeter, the retention member being configured to retain the first and second elongated magnetic implants in position and prevent passage thereof through the necrotic area during the healing time period.

2. The system of claim 1 , wherein the at least one of the first and second elongated magnetic implants comprises a housing configured to house a magnet therein.

3. The system of claim 2 , wherein the retention member comprises a flange or a series of flanges that is integral with the housing.

4. The system of claim 2 , wherein the retention member comprises a flange or a series of flanges that is discrete from the housing.

5. The system of claim 2 , wherein the retention member comprises a series of connection tabs extending around the outer side wall of the housing of the at least one of the first and second elongated magnetic implants, the connection tabs being provided in a spaced-apart relationship relative to one another.

6. The system of claim 5 , wherein the retention member comprises a continuous rim extending circumferentially around the outer side wall of the housing of the at least one of the first and second elongated magnetic implants, the connection tabs extending between the outer side wall of the housing and the continuous rim.

7. The system of claim 6 , wherein the continuous rim has a continuous rim height and each of the connection tabs has a connection tab height, the continuous rim height being larger than the connection tab height.

8. The system of claim 5 , wherein the continuous rim is aligned on a plane that is offset from the compression surface of the at least one of the first and second elongated magnetic implants.

9. The system of claim 5 , wherein an upper portion and a lower portion of the continuous rim are curved.

10. The system of claim 9 , wherein the upper portion and the lower portion are symmetrical, upwardly and downwardly from a corresponding one of the connection tabs.

11. The system of claim 2 , wherein the retention member and the housing are made of a same material.

12. The system of claim 2 , wherein the retention member and the housing are made of a different material.

13. The system of claim 1 , wherein the retention member comprises a flange or a series of flanges.

14. The system of claim 13 , wherein the flange extends continuously around substantially an entire periphery of the outer side wall of the at least one of the first and second elongated magnetic implants.

15. The system of claim 1 , wherein the retention member has a T-shaped cross-section.

16. The system of claim 1 , wherein the retention member comprises at least one of a bioerodible material, a biodegradable material, and a bioresorbable material.

17. The system of claim 1 , wherein the retention member comprises at least two materials, the at least two materials having a different dissolution rate or a different degradation rate once implanted in a given environment.

18. The system of claim 1 , wherein the retention member comprises at least one notch or spot having a dissolution rate or a degradation rate that is different from a remainder thereof once implanted in a given environment.

19. The system of claim 1 , wherein each one of the first and second elongated magnetic implants comprises a corresponding retention member extending outwardly therefrom, the corresponding retention member of the first and second elongated magnetic implants being made of a same material.

20. The system of claim 1 , wherein each one of the first and second elongated magnetic implants comprises a corresponding retention member extending outwardly therefrom, the corresponding retention member of the first magnetic implant being made from a different material than the corresponding retention member of the second magnetic implant.

21. The system of claim 20 , wherein the first elongated magnetic implant is configured for implantation in a strongly acidic environment and the second elongated magnetic implant is configured for implantation in a weakly acidic environment, and once implanted in the strongly acidic environment and in the weak acidic environment respectively, the first and second retention member have a similar dissolution rate or degradation rate.

22. The system of claim 1 , wherein an outwardly-extending inner surface of the retention member is substantially flat.

23. The system of claim 1 , wherein an outwardly-extending inner surface of the retention member comprises a curvature.

24. The system of claim 1 , wherein each one of the first and second elongated magnetic implants comprises a corresponding retention member, the corresponding retention members being provided such that a gap is defined between outwardly-extending inner surfaces of the corresponding retention members of the first and second elongated magnetic implants once implanted in the digestive tract.

25. The system of claim 1 , wherein the retention member comprises a portion that is foldable against the at least one of the first and second elongated magnetic implants for delivery within the digestive tract, the foldable portion being configured to unfurl once the at least one of the first and second elongated magnetic implants is implanted within the digestive tract.

26. The system of claim 1 , wherein the retention member is configured to adopt a retracted configuration for delivery within the digestive tract, and an expanded configuration once the at least one of the first and second elongated magnetic implants is implanted within the digestive tract.

27. A system for forming an anastomosis between two adjacent walls of a digestive tract, the system comprising:

first and second magnetic implants having an annular shape and each comprising an outer side wall and a tissue-contacting portion extending inwardly from a compression perimeter defined by the outer side wall, the first and second elongated magnetic implants being configured to magnetically couple to each other through the two adjacent walls of the digestive tract to compress a portion of the two adjacent walls therebetween and form a necrotic area that becomes surrounded by a scarred edge following a healing time period; and

a retention member extending outwardly from the outer wall of at least one of the first and second elongated magnetic implants to define a retention member perimeter that is larger than the compression perimeter, the retention member being configured to retain the first and second elongated magnetic implants in position and prevent passage thereof through the necrotic area during the healing time period.

28. The system of claim 27 , wherein the retention member comprises a flange or a series of flanges.

29. The system of claim 27 , wherein the flange extends continuously around substantially an entire periphery of the outer side wall of the at least one of the first and second elongated magnetic implants.

30. The system of claim 27 , wherein the retention member comprises a continuous rim extending circumferentially around the outer side wall of the at least one of the first and second elongated magnetic implants.

31. The system of claim 27 , wherein the retention member has a T-shaped cross-section.

32. The system of claim 27 , wherein the at least one of the first and second elongated magnetic implants comprises a housing configured to house a magnet therein.

33. The system of claim 32 , wherein the magnet housed in the housing comprises a plurality of magnets.

34. The system of claim 32 , wherein the housing comprises a flat compression surface forming the tissue-contacting portion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2023
From: GAGNER, MICHEL; KRINKE, TODD A.; THAURE, THIERRY
To: GT METABOLIC SOLUTIONS, INC.
Reel/Frame 063699/0301 →
Continuity (3)
Continuation 17477790 · Sep 17, 2021
Provisional Application 63080363 · Sep 18, 2020
Related Publication 20230293178A1 · Sep 21, 2023
References Cited (91)
US 5690656A · Cope et al. · 1997 [cited by applicant]
US 6632229B1 · Yamanouchi · 2003 [cited by applicant]
US 6719768B1 · Cole et al. · 2004 [cited by applicant]
US 7282057B2 · Surti et al. · 2007 [cited by applicant]
US 7909837B2 · Crews et al. · 2011 [cited by applicant]
US 8043290B2 · Harrison et al. · 2011 [cited by applicant]
US 8262680B2 · Swain et al. · 2012 [cited by applicant]
US 8506516B2 · Kassab et al. · 2013 [cited by applicant]
US 8556919B2 · Aguirre et al. · 2013 [cited by applicant]
US 8623036B2 · Harrison et al. · 2014 [cited by applicant]
US 8679139B2 · Aguirre et al. · 2014 [cited by applicant]
US 8685046B2 · Viola · 2014 [cited by applicant]
US 8728105B2 · Aguirre et al. · 2014 [cited by applicant]
US 8794243B2 · Deem et al. · 2014 [cited by applicant]
US 8828031B2 · Fox et al. · 2014 [cited by applicant]
US 8845663B2 · Chmura · 2014 [cited by applicant]
US 8915915B2 · Harrison et al. · 2014 [cited by applicant]
US 9168041B2 · Zaritsky et al. · 2015 [cited by applicant]
US 9226753B2 · Surti et al. · 2016 [cited by applicant]
US 9943335B2 · Gittard et al. · 2018 [cited by applicant]
US 10039550B2 · Altman · 2018 [cited by applicant]
US 10182821B2 · Lukin et al. · 2019 [cited by applicant]
US 10285703B2 · Viola · 2019 [cited by applicant]
US 10342544B2 · Bakos et al. · 2019 [cited by applicant]
US 10376400B2 · Moguckin, Jr. · 2019 [cited by applicant]
US 10448954B2 · Mcweeney et al. · 2019 [cited by applicant]
US 10555735B2 · Bakos et al. · 2020 [cited by applicant]
US 10568630B2 · Hernandez et al. · 2020 [cited by applicant]
US 10624643B2 · Hunt et al. · 2020 [cited by applicant]
US 10624644B2 · Bakos et al. · 2020 [cited by applicant]
US 10631865B2 · Bakos et al. · 2020 [cited by applicant]
US 10682143B2 · Hernandez et al. · 2020 [cited by applicant]
US 10779831B2 · Lukin et al. · 2020 [cited by applicant]
US 10813642B2 · Beisel et al. · 2020 [cited by applicant]
US 10952732B2 · Binmoeller et al. · 2021 [cited by applicant]
US 20060036267A1 · Saadat et al. · 2006 [cited by applicant]
US 20060271107A1 · Harrison et al. · 2006 [cited by applicant]
US 20070276378A1 · Harrison et al. · 2007 [cited by applicant]
US 20080114384A1 · Chang et al. · 2008 [cited by applicant]
US 20080208224A1 · Surti et al. · 2008 [cited by applicant]
US 20090048618A1 · Harrison et al. · 2009 [cited by applicant]
US 20090125042A1 · Mouw · 2009 [cited by applicant]
US 20090227828A1 · Swain et al. · 2009 [cited by applicant]
US 20100036399A1 · Viola · 2010 [cited by applicant]
US 20100179510A1 · Fox et al. · 2010 [cited by applicant]
US 20110009886A1 · Gagner et al. · 2011 [cited by applicant]
US 20110144560A1 · Gagner et al. · 2011 [cited by applicant]
US 20110160752A1 · Aguirre · 2011 [cited by applicant]
US 20110295055A1 · Albrecht et al. · 2011 [cited by applicant]
US 20110295285A1 · Mcweeney et al. · 2011 [cited by applicant]
US 20130253548A1 · Harrison et al. · 2013 [cited by applicant]
US 20130325042A1 · Fabian et al. · 2013 [cited by applicant]
US 20140236064A1 · Binmoeller et al. · 2014 [cited by applicant]
US 20140309669A1 · Fabian et al. · 2014 [cited by applicant]
US 20150057687A1 · Gittard et al. · 2015 [cited by applicant]
US 20150164508A1 · Hernandez et al. · 2015 [cited by applicant]
US 20150182224A1 · Altman · 2015 [cited by applicant]
US 20160022266A1 · Lukin et al. · 2016 [cited by applicant]
US 20160262761A1 · Beisel et al. · 2016 [cited by applicant]
US 20160287257A1 · Fabian et al. · 2016 [cited by applicant]
US 20160324523A1 · Lukin et al. · 2016 [cited by applicant]
US 20170035425A1 · Fegelman et al. · 2017 [cited by applicant]
US 20170265866A1 · Ryou et al. · 2017 [cited by applicant]
US 20180028186A1 · Yamanouchi · 2018 [cited by applicant]
US 20180214149A1 · Hunt et al. · 2018 [cited by applicant]
US 20180214150A1 · Bakos et al. · 2018 [cited by applicant]
US 20180214152A1 · Bakos et al. · 2018 [cited by applicant]
US 20180296218A1 · Binmoeller et al. · 2018 [cited by applicant]
US 20180361127A1 · Gray et al. · 2018 [cited by applicant]
US 20190133678A1 · Pate et al. · 2019 [cited by applicant]
US 20190183507A1 · Baillargeon · 2019 [cited by applicant]
US 20190261998A1 · Altman et al. · 2019 [cited by applicant]
US 20190274687A1 · Wang et al. · 2019 [cited by applicant]
US 20200008834A1 · Cauche et al. · 2020 [cited by applicant]
US 20200129283A1 · Swensgard et al. · 2020 [cited by applicant]
US 20200138438A1 · Harrison et al. · 2020 [cited by applicant]
US 20200323530A1 · Sharma · 2020 [cited by applicant]
EP 1493391B1 · 2009 [cited by applicant]
EP 2207488B1 · 2012 [cited by applicant]
EP 2538852A1 · 2013 [cited by applicant]
EP 3267905A1 · 2018 [cited by applicant]
EP 2260752B1 · 2018 [cited by applicant]
EP 3573542A1 · 2019 [cited by applicant]
EP 3487418A4 · 2020 [cited by applicant]
WO WO2014055193A1 · 2014 [cited by applicant]
WO WO2016082481A1 · 2016 [cited by applicant]
WO WO2019077218A1 · 2019 [cited by applicant]
WO WO2019232526A1 · 2019 [cited by applicant]
WO WO2019232527A1 · 2019 [cited by applicant]
WO WO2021207821 · 2021 [cited by applicant]
International Search Report for PCT/US2021/050879, dated Dec. 20, 2021, 3 pages. [cited by applicant]